Technology transfer of reporter VN assay

Ended Definitive Contract Awarded Last action

Contract number
W911QY21C0012
Awardee
Awarding agency
Obligated
$2,195,778

Award facts

Opportunity
Contract value 16% obligated
  • $2,195,778.34 Current, with exercised options
  • $13,593,328.34 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Two Step
Pricing
Firm Fixed Price
Place of performance
St Cloud, MN 56303, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00008 · Covid-19 action modification to fund clin 001202 for UAC reimbursement and DE-obligate remaining funds from contract. -$457,633
Other Administrative Action P00007 · Admin modification to correct addition of funding for REA payment previously DE-obed from clin 0002 and RE-obed to clin 0011 on modification P00005. No change… $0
Other Administrative Action P00006 · Admin modification to correct the removal of SOW on MOD P00003 and to change the admin office dodaac to W58P05 $0
Change Order P00005 · REA for 1) changes in standard operating procedures related to laboratory service requirements 2) shipping of sera samples to required location. $0
Other Administrative Action P00004 · Technlology transfer of wild type assay $0
Other Administrative Action P00003 · Modification to extend clin 0004 POP from 8 NOV 21 to 31 JAN 22 under the authority of far clause 52.217-8 option to extend services. $0
Other Administrative Action P00002 $0
Supplemental Agreement for work within scope P00001 · Technlology transfer of wild type assay $1,637,447
Original award $1,015,964

About this award

This definitive contract from the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense (JPEO-CBRND) awards Microbiologics, Inc. $13.6 million to deliver technology transfer of reporter VN assay in support of advanced SARS-CoV-2 medical countermeasure therapeutics. The solicitation sought proposals to manufacture and fill-finish a minimum of 100,000 treatment courses by March 2021 to treat the indicated U.S. population, with candidate therapeutics demonstrating capability for Emergency Use Authorization or FDA approval by end of 2020. The firm fixed-price contract runs from November 2020 through December 2022 for performance in St. Cloud, Minnesota and supports JPEO-CBRND and Biomedical Advanced Research and Development Authority's Commercial Solutions Opening solicitation to strengthen the U.S. medical response against COVID-19. There is no set-aside designation for this award to Microbiologics, Inc. for reporter VN assay technology transfer.

Quick answers

Who was awarded contract W911QY21C0012?

W911QY21C0012 was awarded to Microbiologics, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on November 9, 2020.

How much is contract W911QY21C0012 worth?

The government has obligated $2,195,778 on W911QY21C0012. Its potential value, with all options, is $13,593,328.

Which agency awarded contract W911QY21C0012?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY21C0012, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W911QY21C0012 competed?

The extent of competition for W911QY21C0012 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award